Horizon Pharma plc to Present at Two Investor Conferences in May

DUBLIN, IRELAND--(Marketwired - May 3, 2016) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced that the company will present at the following conferences in May:

Bank of America Merrill Lynch 2016 Health Care Conference

• Date: May 11, 2016
• Presentation Time: 4:20 p.m. PT
• Location: Las Vegas, NV

UBS Global Healthcare Conference

• Date: May 25, 2016
• Presentation Time: 11 a.m. ET
• Location: New York City, NY

The above conference presentations, which will include updates of Horizon's business, will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.  A replay of the webcasts will be available for the events with presentations.

About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets nine medicines through its orphan, primary care and rheumatology business units. Horizon Pharma's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.

Contacts:

Investors:
John Thomas
Executive Vice President, Strategy and Investor Relations
[e-mail]

Tina Ventura
Vice President, Investor Relations
[e-mail]

U.S. Media:
Geoff Curtis
Senior Vice President, Corporate Communications
[e-mail]

Ireland Media:
Ray Gordon
Gordon MRM
[e-mail]